Dermatology and Therapy (Dec 2018)
Clinical Goals and Barriers to Effective Psoriasis Care
- Bruce E. Strober,
- Joelle M. van der Walt,
- April W. Armstrong,
- Marc Bourcier,
- Andre V. E. Carvalho,
- Edgardo Chouela,
- Arnon D. Cohen,
- Claudia de la Cruz,
- Charles N. Ellis,
- Andrew Y. Finlay,
- Alice B. Gottlieb,
- Johann E. Gudjonsson,
- Lars Iversen,
- C. Elise Kleyn,
- Craig L. Leonardi,
- Charles W. Lynde,
- Caitriona Ryan,
- Colin T. Theng,
- Fernando Valenzuela,
- Ronald Vender,
- Jashin J. Wu,
- Helen S. Young,
- Alexa B. Kimball
Affiliations
- Bruce E. Strober
- University of Connecticut Health Center
- Joelle M. van der Walt
- International Psoriasis Council
- April W. Armstrong
- University of Southern California
- Marc Bourcier
- Faculty of Medicine, Sherbrooke University
- Andre V. E. Carvalho
- Moinhos de Vento Hospital Complex
- Edgardo Chouela
- University of Buenos Aires
- Arnon D. Cohen
- Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev
- Claudia de la Cruz
- Clínica Dermacross
- Charles N. Ellis
- Department of Dermatology, University of Michigan Medical School
- Andrew Y. Finlay
- Department of Dermatology and Academic Wound Healing, Division of Infection and Immunity, School of Medicine, Cardiff University
- Alice B. Gottlieb
- Icahn School of Medicine at Mount Sinai
- Johann E. Gudjonsson
- Department of Dermatology, University of Michigan Medical School
- Lars Iversen
- Department of Dermatology, Aarhus University Hospital
- C. Elise Kleyn
- The Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust
- Craig L. Leonardi
- St Louis University Medical School
- Charles W. Lynde
- University of Toronto
- Caitriona Ryan
- Blackrock Clinic Dublin and University College Dublin
- Colin T. Theng
- Department of Dermatology, National Skin Centre
- Fernando Valenzuela
- Department of Dermatology, Universidad de Chile
- Ronald Vender
- Dermatrials Research Inc & Venderm Innovations in Psoriasis
- Jashin J. Wu
- Dermatology Research and Education Foundation
- Helen S. Young
- The Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust
- Alexa B. Kimball
- Harvard Medical Faculty Physicians, Beth Israel Deaconess Medical Center
- DOI
- https://doi.org/10.1007/s13555-018-0279-5
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 5 – 18
Abstract
Abstract Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear expectations might ultimately encourage undertreated psoriasis patients to seek care in an era in which great gains in therapeutic efficacy have been achieved. Here, we discuss the option for early treatment of all categories of psoriasis to alleviate disease impact while emphasizing the need for more focused attention for psoriasis patients with mild and moderate forms of this autoimmune disease. In addition, we encourage policy changes to keep pace with the innovative therapies and clinical science and highlight the demand for greater understanding of treatment barriers in resource-poor countries.
Keywords
